AAAAAA

   
Results: 1-12 |
Results: 12
Potent and selective bicyclic lactam inhibitors of thrombin. Part 4: Transition state inhibitors
Authors: Bachand, B Tarazi, M St-Denis, Y Edmunds, JJ Winocour, PD Leblond, L Siddiqui, MA
Citation: B. Bachand et al., Potent and selective bicyclic lactam inhibitors of thrombin. Part 4: Transition state inhibitors, BIOORG MED, 11(3), 2001, pp. 287-290
Novel bicyclic lactam inhibitors of thrombin: Potency and selectivity optimization through P1 residues
Authors: Levesque, S St-Denis, Y Bachand, B Preveille, P Leblond, L Winocour, PD Edmunds, JJ Rubin, JR Siddiqui, MA
Citation: S. Levesque et al., Novel bicyclic lactam inhibitors of thrombin: Potency and selectivity optimization through P1 residues, BIOORG MED, 11(24), 2001, pp. 3161-3164
Descriptive epidemiology of death in horses: results from a survey of French speaking equine practitioners in four countries.
Authors: Leblond, A Leblond, L Sabatier, P Sasco, AJ
Citation: A. Leblond et al., Descriptive epidemiology of death in horses: results from a survey of French speaking equine practitioners in four countries., ANN MED VET, 145(2), 2001, pp. 122
A 5-arm maze enables parallel measures of sustained visuo-spatial attention and spatial working memory in mice
Authors: Durkin, TP Beaufort, C Leblond, L Maviel, T
Citation: Tp. Durkin et al., A 5-arm maze enables parallel measures of sustained visuo-spatial attention and spatial working memory in mice, BEH BRA RES, 116(1), 2000, pp. 39-53
A retrospective evaluation of the causes of death of 448 insured French horses in 1995
Authors: Leblond, A Villard, I Leblond, L Sabatier, P Sasco, AJ
Citation: A. Leblond et al., A retrospective evaluation of the causes of death of 448 insured French horses in 1995, VET RES COM, 24(2), 2000, pp. 85-102
Incorporation of an Asp-Ser sequence to form an RGDS-like motif in hirutonin: The effect on in vitro platelet function
Authors: van Wyk, V Leblond, L Winocour, PD Devine, DV Gyongyossy-Issa, MIC
Citation: V. Van Wyk et al., Incorporation of an Asp-Ser sequence to form an RGDS-like motif in hirutonin: The effect on in vitro platelet function, THROMB RES, 99(4), 2000, pp. 343-352
In vitro and in vivo properties of bicyclic lactam inhibitors: A novel class of low molecular weight peptidomimetic thrombin inhibitors
Authors: Leblond, L Grouix, B Boudreau, C Yang, Q Siddiqui, MA Winocour, PD
Citation: L. Leblond et al., In vitro and in vivo properties of bicyclic lactam inhibitors: A novel class of low molecular weight peptidomimetic thrombin inhibitors, THROMB RES, 100(3), 2000, pp. 195-209
The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: Part 2
Authors: Cody, WL Augelli-Szafran, CE Berryman, KA Cai, CM Doherty, AM Edmunds, JJ He, JX Narasimhan, LS Penvose-Yi, J Plummer, JS Rapundalo, ST Rubin, JR Van Huis, CA Leblond, L Winocour, PD Siddiqui, MA
Citation: Wl. Cody et al., The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: Part 2, BIOORG MED, 9(17), 1999, pp. 2503-2508
The coagulation pathway and antithrombotic strategies
Authors: Leblond, L Winocour, PD
Citation: L. Leblond et Pd. Winocour, The coagulation pathway and antithrombotic strategies, HANDB EXP P, 132, 1999, pp. 1-39
Insertion of the Asp-Ser/Phe sequence in the P ' position of hirutonin provides molecules having both antithrombin and disintegrin activity
Authors: Leblond, L DiMaio, J Winocour, PD
Citation: L. Leblond et al., Insertion of the Asp-Ser/Phe sequence in the P ' position of hirutonin provides molecules having both antithrombin and disintegrin activity, THROMB RES, 93(4), 1999, pp. 171-181
Evaluation of proteinase-activated receptor-1 (PAR(1)) agonists and antagonists using a cultured cell receptor desensitization assay: Activation of PAR(2) by PAR(1)-targeted ligands
Authors: Kawabata, A Saifeddine, M Al-Ani, B Leblond, L Hollenberg, MD
Citation: A. Kawabata et al., Evaluation of proteinase-activated receptor-1 (PAR(1)) agonists and antagonists using a cultured cell receptor desensitization assay: Activation of PAR(2) by PAR(1)-targeted ligands, J PHARM EXP, 288(1), 1999, pp. 358-370
Potent bicyclic lactam inhibitors of thrombin: Part I: P3 modifications
Authors: St-Denis, Y Augelli-Szafran, CE Bachand, B Berryman, KA DiMaio, J Doherty, AM Edmunds, JJ Leblond, L Levesque, S Narasimhan, LS Penvose-Yi, JR Rubin, JR Tarazi, M Winocour, PD Siddiqui, MA
Citation: Y. St-denis et al., Potent bicyclic lactam inhibitors of thrombin: Part I: P3 modifications, BIOORG MED, 8(22), 1998, pp. 3193-3198
Risultati: 1-12 |